Suture Anchor Devices Market (2026 - 2033)

Suture Anchor Devices Market Summary

The global suture anchor devices market size was valued at USD 867.7 million in 2025 and is projected to grow from USD 916.3 million in 2026 to USD 1,356.6 million by 2033, at a CAGR of 5.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.7% in 2025. This expansion is projected to be aided by a rising prevalence of sports injuries that has led to an increase in the demand for suture anchor devices.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Moreover, advancements in surgical techniques and materials incorporated into these devices have significantly contributed to their widespread adoption. Additionally, the rising aging population worldwide, along with prevalent orthopedic conditions, are some of the factors driving market expansion.

In sports medicine and arthroscopic surgery, suture anchors play a crucial role in anchoring soft tissue, including tendons, ligaments, and meniscus, to the bone. For instance, the number of injuries among players under the age of 21 in the Premier League escalated from 34 to 51 during the 2023-24 season. This rise is ascribed to the increasing physical demands imposed on these athletes and the congested fixture schedules they are required to navigate. Such trends underscore the increasing necessity for effective injury prevention and management strategies, particularly with respect to football-related injuries.

To learn more about this report, Download Free Sample Report

The market is also significantly influenced by the rising aging population, who are susceptible to musculoskeletal disorders, joint diseases, and soft tissue injuries. This has increased the demand for effective orthopedic solutions, such as suture anchors, to repair affected ligaments and tendons in aging patients. As per the World Health Organization (WHO), the population aged 60 years and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2030 and more than double to 2.1 billion by 2050. This demographic shift led to a surge in the conduction of orthopedic procedures among the elderly population, addressing conditions such as rotator cuff injuries and joint degeneration. An increase in such procedures is directly influencing the growing adoption and utilization of suture anchor devices to enhance the quality of life for the aging population.

The development of advanced suture anchor devices & surgical techniques is further driving the robust market growth of the suture anchor devices industry. Musculoskeletal injuries, particularly those affecting the shoulders, knees, and ankles, require surgical intervention to restore function and mobility. Suture anchors are essential in these procedures, providing secure fixation for tissues and bones during repair. Hence, the market is witnessing a rise in the adoption of minimally invasive surgeries, technological advancements, and research in suture anchor devices, further propelling its expansion. Additionally, a wide product range in the pipeline and a high market potential in untapped emerging economies are anticipated to serve as attractive opportunities for suture anchor devices during the forecast period.

Market Dynamics

The suture anchor devices market is witnessing robust growth due to the increasing adoption of advanced soft tissue fixation techniques and the rising volume of minimally invasive orthopedic and sports medicine procedures. Anchor suture devices are specialized implantable fixation systems designed to securely attach soft tissues, such as tendons, ligaments, and labrum, to bone during surgical repair.

These devices are available in metallic, bioabsorbable, biocomposite, PEEK, and all-suture configurations and are widely utilized in shoulder instability repair, rotator cuff repair, hip labral repair, knee ligament reconstruction, foot and ankle procedures, elbow surgery, and other orthopedic interventions. The growing prevalence of sports injuries, degenerative musculoskeletal disorders, rotator cuff tears, ligament injuries, and an aging yet physically active population is driving market growth globally. Furthermore, continuous advancements in knotless anchor technologies, all-suture anchors, bioabsorbable materials, minimally invasive arthroscopic techniques, and high-strength suture materials are improving fixation strength, reducing surgical complications, and enhancing patient outcomes, thereby supporting widespread adoption across hospitals, orthopedic specialty centers, ambulatory surgical centers, and sports medicine clinics.

Market Concentration & Characteristics

Regulatory standards, such as FDA (Food and Drug Administration) approvals in the U.S. or CE marking in the European Union, regulate the standards of surgical devices and treatments. Such regulation ensures comprehensive preclinical and clinical assessments, stringent manufacturing practices, and necessary certification for the product to be used in regular practice.

To learn more about this report, Download Free Sample Report

The market for suture anchor devices is subject to comprehensive regulations characterized by stringent guidelines that oversee product safety, effectiveness, and manufacturing procedures. Only a limited number of companies possess the capability to fulfill such stringent requirements and have the expertise required to achieve high manufacturing standards. Owing to this, the suture anchor devices industry is moderately consolidated with limited companies participating in the regional and global market. Smaller enterprises find it difficult to comply with the regulatory criteria or may lack the capacity to invest in the elaborate approval procedures. This scenario leads to a competitive environment in which major players hold a beneficial advantage, thereby restricting opportunities for new market entrants and making the market concentrated.

Analyst Perspective

The suture anchor devices market is positioned at the intersection of several transformative trends in orthopedic surgery, sports medicine, and minimally invasive musculoskeletal care, including the rising prevalence of sports-related injuries, increasing incidence of degenerative joint disorders, growing volume of arthroscopic procedures, and continuous advancements in soft tissue fixation technologies. Healthcare providers are increasingly adopting advanced suture anchor systems that offer superior fixation strength, enhanced biomechanical stability, simplified surgical techniques, and improved tendon-to-bone healing to optimize patient outcomes. Technological innovations in knotless suture anchors, all-suture anchors, bioabsorbable and biocomposite materials, PEEK anchors, double-row repair techniques, and instrument-assisted arthroscopic fixation systems are reshaping the competitive landscape.

Product Insights

Based on product, the absorbable segment accounted for a revenue share of 33.9% in 2025 and is expected to show the fastest growth of 6.0% CAGR over the forecast period, as these products are designed to degrade over time within the body, eliminating the need for surgical removal. They offer convenience by negating the requirement for follow-up and intervention for anchor removal, thus helping reduce patient discomfort and healthcare costs. Enhanced patient convenience and considerable reduction in treatment costs make absorbable suture anchors an attractive alternative in procedures where long-term fixation is not required. These anchors are particularly advantageous in outpatient procedures, where minimizing the need for follow-up visits and subsequent surgeries is a key priority. Furthermore, advancements in biodegradable materials and the development of innovative formulations that facilitate rapid and efficient degradation are driving increased demand for absorbable suture anchors. Technological innovation is expected to drive further enhancements in the performance of these devices, leading to improved healing outcomes and a reduced risk of complications.

Non-absorbable products are expected to show significant growth over the forecast period, aided by their use in orthopedic procedures to secure sutures in bone and maintain their structural integrity. They are designed to provide long-term fixation for ligament and tendon repairs and are commonly composed of polyester, polyethylene, and nylon. They offer reliable and long-lasting fixation, contributing significantly to their widespread utilization across various medical applications. The inherent durability and non-degradable properties of non-absorbable anchors play a critical role in achieving stability during recovery.  Their widespread use across various orthopedic surgeries has contributed significantly to their market dominance compared to absorbable suture anchors.

Material Insights

Based on material, the bio-absorbable suture anchor segment led the market with the largest revenue share of 50.4% in 2025 and is expected to experience the fastest growth during the forecast period, driven by increasing preference for implants that gradually degrade after tissue healing. These anchors can reduce the need for permanent foreign material and may minimize long-term complications associated with retained implants. Growing adoption in sports medicine and minimally invasive orthopedic procedures is further supporting demand. Advances in polymer formulations and implant design are improving mechanical performance, biocompatibility, and controlled absorption characteristics. In addition, increasing awareness of tissue-friendly fixation approaches and the expanding use of arthroscopic procedures are expected to create favorable opportunities for bio-absorbable suture anchors.

The metallic suture anchor segment is expected to experience the significant growth during the forecast period, attributed by the high mechanical strength, durability, and reliable fixation offered by metallic anchors, particularly in procedures requiring secure soft-tissue attachment. Titanium and other metal-based anchors have been widely adopted across orthopedic and sports medicine procedures due to their established clinical use and predictable performance. Their ability to withstand substantial tensile and shear forces supports utilization in rotator cuff repair, labral repair, and other ligament and tendon fixation procedures. Continued demand for durable fixation solutions is expected to sustain the segment’s market position.

Tying Type Insights

Based on tying type, knotless segment led the market with the largest revenue share of 62.9% in 2025. These anchors simplify the surgical process by eliminating the need for manual knot tying, reducing procedure time and potential complications associated with knot tying. They offer enhanced tissue preservation and distribute tension evenly across the repaired tissue, improving outcomes and potentially resulting in faster patient rehabilitation. Consistent tension distribution is essential for proper tissue healing, as knot-related inconsistencies offer uniform tension across the repair site.

The knotted sutures segment is expected to experience significant growth due to their ongoing utilization in specific orthopedic and surgical procedures where knotting is the preferred technique for securing tissue. The demand for knotted sutures is propelled by the dependability and familiarity associated with traditional knot-tying techniques that enhance surgeons' control over tension and flexibility during complex repairs. Furthermore, knotted sutures are more economical compared to knotless alternatives, rendering them a preferred choice in markets where cost factors are critical. Knotted sutures maintain their value compared to knotless alternatives, particularly in procedures where precision and control are paramount.

End-use Insights

Based on end use, the hospitals segment led the market with the largest revenue share of 45.9% in 2025. Hospitals conduct more orthopedic procedures, including those involving suture anchors for ligament and tendon repairs. The specialized orthopedic departments and resources required for complex orthopedic surgeries contribute to the significant usage of suture anchor devices in these facilities. Factors such as the increasing number of surgeries performed in hospitals, the establishment of multi-specialty hospitals worldwide, and the rapid adoption of more advanced biosurgery treatment procedures have further fostered the suture anchor devices industry.

To learn more about this report, Download Free Sample Report

Hospitals are prioritizing patient care and surgical outcomes, leading to a surge in demand for suture anchor devices. This is due to the adoption of minimally invasive techniques, which reduce recovery times and enhance patient outcomes. The growth of hospital networks, especially in emerging markets with improved healthcare access, is also boosting the market as hospitals expand their orthopedic departments to meet the increasing demand for orthopedic surgeries. Additionally, the rising geriatric population, increasing incidences of knee injuries, and rapid adoption of advanced orthopedic surgical equipment have also contributed to hospitals being the leading end-use segment.

The ambulatory surgical centers segment is estimated to register the fastest CAGR over the forecast period. Ambulatory surgical centers have gained substantial popularity due to their cost-effectiveness, efficiency in performing minor surgeries, and advancements in medical technologies, allowing more procedures to be performed outside traditional hospital settings. Additionally, the shift toward outpatient procedures for orthopedic surgeries has increased the demand for suture anchor devices in these centers.

Regional Insights

North America dominated the suture anchor devices market with the largest revenue share of 40.7% in 2025. This dominance can be attributed to several key factors, including the region's advanced healthcare landscape and its capacity to support the widespread adoption of innovative medical technologies, including suture anchor products. The presence of a large patient population, favorable reimbursement policies in the healthcare system, and a higher number of research and development activities are also contributing to the market growth. Furthermore, North America is a hub for research and development (R&D) activities in the medical device industry. Leading companies in the suture anchor industry are based in the U.S., thus driving continuous innovation and technological advancements in anchor design, materials, and performance. Key players such as Smith & Nephew, Stryker Corporation, and Johnson & Johnson are headquartered in North America, contributing to the region's market dominance. Moreover, the increasing number of surgeries performed in hospitals, the establishment of multi-specialty hospitals, and the rapid adoption of more advanced biosurgery treatment procedures have all contributed to North America's dominance in the market for suture anchor devices.

To learn more about this report, Download Free Sample Report

U.S. Suture Anchor Devices Market Trends

The suture anchor devices market in the U.S. held the largest share in the North America region in 2025. The country's ability to afford medical treatment and a rise in the adoption rate of suture anchor products are the major factors contributing to market growth. Additionally, the high prevalence of sports-related injuries has prompted a substantial demand for orthopedic interventions, stimulating the usage of suture anchors in repairing ligament and tendon injuries.

In adults aged above 75 years, hip fractures become the most common injury area. Fractures account for 16% of all musculoskeletal injuries in the U.S. annually. Over 40% of fractures take place at home. These factors collectively set the U.S. as the leading country in the suture anchor device market, with the highest revenue share and a strong outlook for continued dominance.

Furthermore, the demand for precise treatments in complex surgeries is rising due to the growing focus on personalized surgical solutions. The expansion of outpatient surgical centers and the trend toward early discharge from hospitals have further increased the demand for these devices. Moreover, the U.S. has a favorable regulatory environment, with medical device advances subject to rigorous yet rapid clearance processes. The FDA's quick clearance of new goods and the country's significant clinical research and testing have resulted in the development and widespread use of cutting-edge suture anchor devices. This regulatory framework and a culture of early technological adoption place the U.S. as a leader in the suture anchor industry.

Europe Suture Anchor Devices Market Trends

The suture anchor devices market in Europe is projected to grow at a considerable CAGR from 2026 to 2033. The demand for suture anchor devices in Europe is rising due to several factors. There is an elderly population that results in more joint issues and musculoskeletal disorders, and this is amplifying the need for effective therapies. Sports injuries also elevate the demand, particularly among active youth. The shift towards minimally invasive surgery promotes the use of suture anchors, as they facilitate smaller incisions and quicker recovery. The inclination for arthroscopic surgery is also on the rise, as it inflicts less tissue harm and diminishes complications.

Moreover, surgeons in Europe are receiving training in advanced, less invasive methods, resulting in greater utilization of suture anchor devices. Educational programs and workshops on these technologies are also on the rise. Furthermore, improved reimbursement policies for orthopedic surgeries are helping patients afford treatments using these devices which is helping in boosting market growth. Innovative materials, such as bio-absorbable alternatives, boost the dependability of these devices, making them increasingly favored in surgical procedures. Altogether, these elements highlight the dynamic characteristics of the economy and its adaptability to shifting technological advancements and healthcare requirements.

Asia Pacific Suture Anchor Devices Market Trends

Asia Pacific is expected to advance with the fastest growth rate during the forecast period, with a CAGR of 4.6%. The rising geriatric population increases the incidence of orthopedic conditions, necessitating more interventions involving suture anchors. Furthermore, the Asia-Pacific region is experiencing a substantial movement toward expanding healthcare access in rural and disadvantaged areas. The spread of healthcare services into these areas and a growing middle class are driving up demand for modern medical procedures, such as orthopedic surgery. This tendency, particularly in countries with huge populations such as India and China, has been critical in promoting suture anchor devices since the number and diversity of procedures needing these devices continue to rise. Moreover, continuous technological advancements, increased awareness about advanced medical treatments, and expanding investments in healthcare contribute to the anticipated rapid growth rate of the market for suture anchor devices in the Asia Pacific region.

The rise in sports participation is not confined to established markets such as North America and Europe. It is extending to emerging economies in Asia Pacific. The countries in the region continue to develop and enhance their healthcare infrastructure, and there is a growing demand for advanced orthopedic solutions, including suture anchor devices. This is particularly evident as sports injuries in these regions are increasingly managed through advanced surgical techniques.

Japan accounted for the largest regional share in the market for suture anchor devices in 2025. The economy has witnessed a surge in technological advancements and research in the field of suture anchor devices. Additionally, Japan's efficient and transparent regulatory framework for medical devices encourages the development and approval of new suture anchor products. The country is home to several leading orthopedic companies, such as DePuy Synthes and Arthrex, which have a strong presence in the market. These factors collectively contribute to Japan's leading position in the Asia Pacific market for suture anchor devices, reflecting the region's robust growth and potential for further expansion.

Key Suture Anchor Devices Company Insights

Some of the dominant players operating in the market for suture anchor devices include Smith & Nephew plc; Zimmer Biomet Holdings Inc.; CONMED Corporation; Arthrex, Inc.; Johnson and Johnson (DePuy Synthes, Inc.); Stryker Corporation; Wright Medical; and OrthoMed.

• Smith & Nephew plc is a global medical product company specializing in orthopedic reconstruction, sports medicine, and wound management. It is recognized for its extensive array of orthopedic products, including advanced joint replacement systems, which have augmented its footprint in both emerging and established markets. Their sports medicine division, which emphasizes minimally invasive surgical solutions, drives significant growth in arthroscopic procedures, especially for tendon and ligament repairs.

• Zimmer Biomet Holdings Inc. offers innovative musculoskeletal healthcare solutions, offering a broad spectrum of products and services in orthopedics, spine, dental implants, and more. The company’s concentration on personalized care and advancements in robotics and 3D printing technologies for joint replacements contribute considerable value to its product offerings. Their emphasis on enhancing surgical solutions, particularly regarding patient-specific products such as custom implants, facilitates better surgical outcomes and quicker recovery periods.

• CONMED Corporation operates in over 80 countries worldwide. The company focuses on minimally invasive surgical devices and equipment for arthroscopy, providing solutions for orthopedic surgeries and sports medicine. This focus has resulted in the creation of state-of-the-art minimally invasive surgical instruments, improving accuracy and reducing patient recovery periods. The firm’s commitment to delivering superior arthroscopic equipment has established it as a reliable collaborator for orthopedic surgeons across the globe.

Meanwhile, Parcus Medical and Enovis Corporation are some of the emerging players operating in the suture anchor device market.

• Parcus Medical is a medical device company that offers over 400 innovative products in more than 60 countries worldwide, with a direct selling presence in countries outside the U.S. Their global presence, coupled with an emphasis on innovation and surgical solutions, places them in a strong position for sustained growth in the competitive medical device industry.

• Enovis Corporation is a medical device company specializing in developing orthopedic implants and instruments for spine surgery. It has positioned itself as a prominent entity in designing and developing these implants and instruments. Enovis Corporation focuses on improving surgical outcomes and patient recovery durations.

Key Suture Anchor Devices Companies:

The following key companies have been profiled for this study on the suture anchor devices market. 

• Smith & Nephew, plc.
• Zimmer Biomet Holdings, Inc.
• CONMED Corporation
• Arthrex, Inc.
• Johnson & Johnson Services, Inc. (DePuy Synthes, Inc.)
• Stryker (Wright Medical Group, Inc.)
• Parcus Medical, LLC (Medacta International)
• OrthoMed, Inc.
• Enovis Corporation
• Medtronic

Recent Developments

• Since May 2024, nine suture anchor devices have been in various stages of development globally, with six in the early stages and two in the late stages. These innovations aim to enhance the effectiveness of soft tissue fixation in orthopedic surgeries. Key players engaged in the ongoing advancement of Suture Anchors comprise KeriMedical, Magnesium Development Company, Parcus Medical, San Francisco VA Medical Center, SINTX Technologies, University of Pittsburgh, DePuy Synthes, and Hospital for Special Surgery.

• In September 2023, at the 2023 Orthopaedic Summit (OSET) Annual Meeting, Anika Therapeutics, Inc. announced the launch of their RevoMotion Reverse Shoulder Arthroplasty System (RSA). The company also showcased the Integrity Implant System and the X-Twist Fixation System at the event. Anika's advanced shoulder portfolio, which includes the recently introduced X-Twist suture anchors, aligns with the increasing demand for suture anchor devices in the orthopedic market.

• In December 2022, Stryker launched Citrefix, a suture anchor system for ankle and foot surgical procedures, leveraging Citregen biomaterial that is designed to support bone regeneration and the natural healing process. Citregen, a bioresorbable substance, has been designed to emulate native bone structure and chemistry.

Global Suture Anchor Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global suture anchor devices market report on the basis of product, material, tying type, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Absorbable

  • Non-absorbable

• Material Outlook (Revenue, USD Million, 2018- 2033)

  • Metallic Suture Anchor

  • Bio-absorbable Suture Anchor

  • Others

• Tying Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Knotted Suture Anchors

  • Knotless

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Ambulatory Surgical Centers

  • Clinics

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The suture anchor devices Market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each suture anchor

Delivered Customizations

This report has been delivered with the following In-depth customizations